The National Institutes of Health recently unveiled a collaborative program that will match researchers with a selection of pharmaceutical industry compounds to help scientists explore new treatments for patients. NIH’s new National Center for Advancing Translational Sciences (NCATS) has partnered initially with Pfizer, AstraZeneca, and Eli Lilly and Company which have agreed to make dozens of their compounds available for this initiative’s pilot phase.
Almost half of all Americans take at least one prescription drug . Over 20% of the population takes three or more prescription drugs a month . Not taking a medication — or taking too much or too little — can actually make many conditions worse. Drug interactions can also make a drug ineffective or cause serious adverse reactions.
How much do you know about the medicines you’re taking?
What is your prescription drug IQ?